Literature DB >> 22372905

Pretransfusion testing practices in North America, 2005-2010: an analysis of the College Of American Pathologists Interlaboratory Comparison Program J-survey data, 2005-2010.

Katharine A Downes1, Ira A Shulman.   

Abstract

CONTEXT: Data collection and analysis of the College of American Pathologists (CAP) Interlaboratory Comparison Program (Proficiency Testing) J-Survey results provide insights into North American pretransfusion compatibility testing practices and trends.
OBJECTIVES: To assess current North American manual testing practices for ABO grouping, rhesus (Rh) typing, antibody screening, and crossmatching using CAP proficiency testing data.
DESIGN: Analysis of the CAP Interlaboratory Comparison Program J-Survey data (2005-2010) to identify laboratory methods used for ABO grouping, Rh typing, antibody screening, and crossmatching. Data were analyzed by test method using Microsoft (Redmond, Washington) Excel software.
RESULTS: The method used most often in ABO grouping and Rh typing was tube testing. Many laboratories also used tube testing for antibody detection and crossmatching, but during the study period, the proportion of laboratories using gel-based methodologies increased considerably.
CONCLUSIONS: Most North American CAP laboratories continue to use tube methods for ABO/Rh testing. Use of gel-based methodologies increased during the past 5 years for antibody screening and crossmatching.

Entities:  

Mesh:

Year:  2012        PMID: 22372905     DOI: 10.5858/2011-0127-CPR.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  3 in total

1.  Can the interval between antibody identifications be increased for alloimmunized patients?

Authors:  Cheryl Goss; Scott T Avecilla; Jennifer Garbaini; Diana Degtyaryova; Dian Lo; Dustin Y M Chang; Melissa Cushing
Journal:  Transfusion       Date:  2015-10-12       Impact factor: 3.157

2.  Frequencies and specificities of "enzyme-only" detected erythrocyte alloantibodies in patients hospitalized in austria: is an enzyme test required for routine red blood cell antibody screening?

Authors:  Dietmar Enko; Claudia Habres; Franz Wallner; Barbara Mayr; Gabriele Halwachs-Baumann
Journal:  J Blood Transfus       Date:  2014-03-25

3.  Performance Assessment of Internal Quality Control (IQC) Products in Blood Transfusion Compatibility Testing in China.

Authors:  Gui-Ping Xu; Li-Fang Wu; Jing-Jing Li; Qi Gao; Zhi-Dong Liu; Qiong-Hua Kang; Yi-Jun Hou; Luo-Chuan Zhang; Xiao-Mei Hu; Jie Li; Juan Zhang
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.